Please find below a list of trials that are currently accruing:
- A Phase I Study of AMG 427 in People with Recurrent or Persistent Acute Myeloid Leukemia
- A Phase I/II Study of SNDX-5613 in People with Recurrent or Persistent Acute Leukemia
- A Phase I Study of BTX-A51 in People with Recurrent or Persistent Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndromes
- A Phase IB/II Study of KRT-232 and Cytarabine or Decitabine in People with Acute Myeloid Leukemia
- A Phase I Study of APR-246 with Venetoclax and Azacitidine in People with Persistent Acute Myeloid Leukemia
- A Phase I Study of Cusatuzumab plus Standard Therapy in People with Newly Diagnosed Acute Myeloid Leukemia
- A Phase I Study of PRT543 in People with Advanced Melanoma and Blood Cancers
- A Phase I Study of CB-5339 for Recurrent or Persistent Acute Myeloid Leukemia or Myelodysplastic Syndromes
- A Phase I Study of CG-806 in People with Acute Myeloid Leukemia
- A Phase I Study of PRT1419 in People with Blood Cancers
- A Phase I Study of LY3410738 in Patients with Advanced Blood Cancers with IDH1 or IDH2 Mutations
If you would like to contact us or refer a patient, please call 646-608-3749.